Table 4 Median price ratios (MPRs) of surveyed antibiotics in various public sector procurement agencies in Delhi
From: Access to antibiotics in New Delhi, India: implications for antibiotic policy
Antibiotic no. | Medicine name | Delhi state EML 2007 | Median MPR | Procurement agencies |
|---|---|---|---|---|
1 | Amoxicillin + Clavulanic acid 500 mg + 125 mg cap/tab | No | 0.91 | MCD, CG1,CG2 |
2 | Amoxicillin 500 mg cap/tab | Yes | 1.22 | MCD, CG2,CPA |
3 | Amoxicillin 250 mg cap/tab | Yes | 1.11 | MCD, CG1,CG2, CPA |
4 | Amoxicillin suspension 25 mg/ml | Yes | 1.04 | MCD,CG1,CG2,CPA |
5 | Amoxicillin + Clavulanic acid Syrup 200 mg + 28.5 mg/5 ml | No | * | MSO,MCD |
6 | Ampicillin Suspension 125 mg/5 ml | Yes | 0.97 | CPA |
7 | Azithromycin 500 mg cap/tab | No | 0.53 | MCD,CG2 |
8 | Benzathine Penicillin Powder 2.4MU/vial | Yes | 0.48 | CG1 |
9 | Cefixime 200 mg cap/tab | No | 0.54 | MCD |
10 | Ceftriaxone injection 1 g/vial | Yes | 0.50 | MSO, MCD, CG1,CG2, CPA |
11 | Cefuroxime axetil 250 mg cap/tab | Yes | 0.64 | MSO,MCD, CPA |
12 | Cefuroxime Suspension 125 mg/5 ml | Yes | 0.43 | CPA |
13 | Cephalexin 500 mg cap/tab | Yes | 0.83 | MCD,CG1,CPA |
14 | Cephalexin Syrup 250 mg/5 ml | Yes | 0.68 | MSO,CG2,CPA |
15 | Ciprofloxacin 500 mg cap/tab | Yes | 0.88 | MCD,CG1,CG2,CPA |
16 | Co-trimoxazole suspension 8 + 40 mg/ml | Yes | 0.76 | MCD,CG1,CG2,CPA |
17 | Doxycycline 100 mg cap/tab | Yes | 1.11 | MCD,CG2,CPA |
18 | Erythromycin powder for suspension 125 mg/5 ml | Yes | 0.67 | CG1,CG2,CPA |
19 | Erythromycin Stearate 250 mg cap/tab | Yes | 1.03 | MSO,MCD,CG1,CG2,CPA |
20 | Gentamicin eye drops 0.3% | Yes | 0.44 | MCD,CG1,CG2,CPA |
21 | Gentamicin injection 40 mg/ml | Yes | 0.77 | MCD,CG1,CG2,CPA |
22 | Norfloxacin 400 mg cap/tab | Yes | 0.75 | MCD,CG1,CG2,CPA |
23 | Ofloxacin 200 mg cap/tab | Yes | 0.59 | MSO,MCD,CG1,CG2,CPA |
24 | Roxithromycin 50 mg cap/tab | Yes | * | MSO,MCD,CPA |